European Medicines Agency recommends authorisation of first medicine for Castleman's disease

View source ↗

Summary

The EMA recommends authorisation of the first medicine specifically for Castleman’s disease, marking a pivotal step in treatment options for this rare condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castleman Disease